Post-Doctoral Research Fellow
Listed on 2026-07-17
-
Research/Development
Research Scientist, Clinical Research, Immunology Research
Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states.
Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
The is seeking a highly motivated Post-Doctoral Research Fellow to work with an interactive collaborative team of scientists. As a part of the Corey lab, Dr. Karsten Eichholz’ research is focused on using lentiviral vectors and RNA lipid nanoparticles to generate CAR T cells ex vivo and in vivo. The mission of the Corey Lab is to make discoveries that lead to development of herpes virus vaccine and novel immunotherapies of viral infections including HIV.
The successful applicant will utilize lentiviral vector and mRNA lipid nanoparticles to generate CAR T cells ex vivo and in vivo and test them in various bioassays and the nonhuman primate model. The other techniques involved will include cloning, flow cytometry, ELISA. The position will require independent research, to be eager to learn new technologies, and the ability to collaborate closely with computational biologists, biostatisticians and other colleagues.
MINIMUM QUALIFICATIONS:
- MD and/or PhD in Biology, Immunology, Biochemistry, Virology or another relevant discipline.
- Track record of productive research.
- Excellent written and verbal communication skills are essential for manuscripts/grants preparation, public presentation, and collaboration with other researchers.
- Ability to work independently and collaboratively in a team.
PREFERRED QUALIFICATIONS:
- Experience in CAR T cells, molecular biology, cloning, immunology, flow cytometry, HIV, lentiviral vectors, and/or RNA LNPs, with RNA LNP expertise being highly desirable.
The annual base salary range for this position is from $80,172 to $95,014, and pay offered will be based on experience and qualifications.
This position may be eligible for relocation assistance.
Although Fred Hutch is not sponsoring most H-1B visas at this time, candidates who already hold an H-1B sponsored by another organization and are currently in the U.S. may be eligible for this position.
Fred Hutchinson Cancer Center offers employees a designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, income-based child care subsidy, tuition reimbursement, paid vacation (22 days per year), paid sick leave (up to 30 calendar days per occurrence of a qualifying reason), paid holidays (13 days per year), and paid parental leave (up to 4 weeks).
If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to Human Resources at hrops or by calling .
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).